Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

1.

Mycobacterium tuberculosis and whole-genome sequencing: how close are we to unleashing its full potential?

Satta G, Lipman M, Smith GP, Arnold C, Kon OM, McHugh TD.

Clin Microbiol Infect. 2017 Nov 3. pii: S1198-743X(17)30623-7. doi: 10.1016/j.cmi.2017.10.030. [Epub ahead of print] Review.

PMID:
29108952
2.

Innate activation of human primary epithelial cells broadens the host response to Mycobacterium tuberculosis in the airways.

Reuschl AK, Edwards MR, Parker R, Connell DW, Hoang L, Halliday A, Jarvis H, Siddiqui N, Wright C, Bremang S, Newton SM, Beverley P, Shattock RJ, Kon OM, Lalvani A.

PLoS Pathog. 2017 Sep 1;13(9):e1006577. doi: 10.1371/journal.ppat.1006577. eCollection 2017 Sep.

3.

Rhinovirus induction of fractalkine (CX3CL1) in airway and peripheral blood mononuclear cells in asthma.

Upton N, Jackson DJ, Nikonova AA, Hingley-Wilson S, Khaitov M, Del Rosario A, Traub S, Trujillo-Torralbo MB, Habibi M, Elkin SL, Kon OM, Edwards MR, Mallia P, Footitt J, Macintyre J, Stanciu LA, Johnston SL, Sykes A.

PLoS One. 2017 Aug 31;12(8):e0183864. doi: 10.1371/journal.pone.0183864. eCollection 2017.

4.

Post-tuberculous fibrosing mediastinitis: a review of the literature.

Wu Z, Jarvis H, Howard LS, Wright C, Kon OM.

BMJ Open Respir Res. 2017 May 8;4(1):e000174. doi: 10.1136/bmjresp-2016-000174. eCollection 2017. Review.

5.

Adverse Effects and Choice between the Injectable Agents Amikacin and Capreomycin in Multidrug-Resistant Tuberculosis.

Arnold A, Cooke GS, Kon OM, Dedicoat M, Lipman M, Loyse A, Chis Ster I, Harrison TS.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e02586-16. doi: 10.1128/AAC.02586-16. Print 2017 Sep.

PMID:
28696239
6.

A Comprehensive Evaluation of Nasal and Bronchial Cytokines and Chemokines Following Experimental Rhinovirus Infection in Allergic Asthma: Increased Interferons (IFN-γ and IFN-λ) and Type 2 Inflammation (IL-5 and IL-13).

Hansel TT, Tunstall T, Trujillo-Torralbo MB, Shamji B, Del-Rosario A, Dhariwal J, Kirk PDW, Stumpf MPH, Koopmann J, Telcian A, Aniscenko J, Gogsadze L, Bakhsoliani E, Stanciu L, Bartlett N, Edwards M, Walton R, Mallia P, Hunt TM, Hunt TL, Hunt DG, Westwick J, Edwards M, Kon OM, Jackson DJ, Johnston SL.

EBioMedicine. 2017 May;19:128-138. doi: 10.1016/j.ebiom.2017.03.033. Epub 2017 Mar 28.

7.

Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK.

Abbara A, Chitty S, Roe JK, Ghani R, Collin SM, Ritchie A, Kon OM, Dzvova J, Davidson H, Edwards TE, Hateley C, Routledge M, Buckley J, Davidson RN, John L.

BMC Infect Dis. 2017 Mar 24;17(1):231. doi: 10.1186/s12879-017-2330-z.

8.

Stratification of Latent Mycobacterium tuberculosis Infection by Cellular Immune Profiling.

Halliday A, Whitworth H, Kottoor SH, Niazi U, Menzies S, Kunst H, Bremang S, Badhan A, Beverley P, Kon OM, Lalvani A.

J Infect Dis. 2017 May 1;215(9):1480-1487. doi: 10.1093/infdis/jix107.

9.

Evaluation of prediagnosis emergency department presentations in patients with active tuberculosis: the role of chest radiography, risk factors and symptoms.

Appleton SC, Connell DW, Singanayagam A, Bradley P, Pan D, Sanderson F, Cleaver B, Rahman A, Kon OM.

BMJ Open Respir Res. 2017 Jan 17;4(1):e000154. doi: 10.1136/bmjresp-2016-000154. eCollection 2017.

10.

Proteomic Analysis of Kveim Reagent Identifies Targets of Cellular Immunity in Sarcoidosis.

Eberhardt C, Thillai M, Parker R, Siddiqui N, Potiphar L, Goldin R, Timms JF, Wells AU, Kon OM, Wickremasinghe M, Mitchell D, Weeks ME, Lalvani A.

PLoS One. 2017 Jan 23;12(1):e0170285. doi: 10.1371/journal.pone.0170285. eCollection 2017.

11.

Drug resistant TB: UK multicentre study (DRUMS): Treatment, management and outcomes in London and West Midlands 2008-2014.

Arnold A, Cooke GS, Kon OM, Dedicoat M, Lipman M, Loyse A, Butcher PD, Ster IC, Harrison TS.

J Infect. 2017 Mar;74(3):260-271. doi: 10.1016/j.jinf.2016.12.005. Epub 2016 Dec 18.

PMID:
27998752
12.

Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis.

Singanayagam A, Manalan K, Connell DW, Chalmers JD, Sridhar S, Ritchie AI, Lalvani A, Wickremasinghe M, Kon OM.

Int J Tuberc Lung Dis. 2016 Dec;20(12):1653-1660.

PMID:
27931342
13.

Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.

Rawson TM, Abbara A, Kranzer K, Ritchie A, Milburn J, Brown T, Adeboyeku D, Buckley J, Davidson RN, Berry M, Kon OM, John L.

Respir Med. 2016 Nov;120:101-108. doi: 10.1016/j.rmed.2016.10.001. Epub 2016 Oct 6.

PMID:
27817806
14.

Tuberculosis or sarcoidosis: Opposite ends of the same disease spectrum?

Agrawal R, Kee AR, Ang L, Tun Hang Y, Gupta V, Kon OM, Mitchell D, Zierhut M, Pavesio C.

Tuberculosis (Edinb). 2016 May;98:21-6. doi: 10.1016/j.tube.2016.01.003. Epub 2016 Jan 18. Review.

PMID:
27156614
15.

Anti-tubercular therapy for intraocular tuberculosis: A systematic review and meta-analysis.

Kee AR, Gonzalez-Lopez JJ, Al-Hity A, Gupta B, Lee CS, Gunasekeran DV, Jayabalan N, Grant R, Kon OM, Gupta V, Westcott M, Pavesio C, Agrawal R.

Surv Ophthalmol. 2016 Sep-Oct;61(5):628-53. doi: 10.1016/j.survophthal.2016.03.001. Epub 2016 Mar 10. Review.

16.

Trapped without a diagnosis: Tumour necrosis factor receptor-associated periodic syndrome (TRAPS).

Kirresh A, Everitt A, Kon OM, DasGupta R, Pickering MC, Lachmann HJ.

Pract Neurol. 2016 Aug;16(4):304-7. doi: 10.1136/practneurol-2015-001342. Epub 2016 Mar 10.

PMID:
26965498
17.

Erratum: RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection.

Jozwik A, Habibi MS, Paras A, Zhu J, Guvenel A, Dhariwal J, Almond M, Wong EH, Sykes A, Maybeno M, Del Rosario J, Trujillo-Torralbo MB, Mallia P, Sidney J, Peters B, Kon OM, Sette A, Johnston SL, Openshaw PJ, Chiu C.

Nat Commun. 2016 Mar 9;7:11011. doi: 10.1038/ncomms11011. No abstract available.

18.

PD-1 Expression and Cytokine Secretion Profiles of Mycobacterium tuberculosis-Specific CD4+ T-Cell Subsets; Potential Correlates of Containment in HIV-TB Co-Infection.

Pollock KM, Montamat-Sicotte DJ, Grass L, Cooke GS, Kapembwa MS, Kon OM, Sampson RD, Taylor GP, Lalvani A.

PLoS One. 2016 Jan 12;11(1):e0146905. doi: 10.1371/journal.pone.0146905. eCollection 2016.

19.

RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection.

Jozwik A, Habibi MS, Paras A, Zhu J, Guvenel A, Dhariwal J, Almond M, Wong EH, Sykes A, Maybeno M, Del Rosario J, Trujillo-Torralbo MB, Mallia P, Sidney J, Peters B, Kon OM, Sette A, Johnston SL, Openshaw PJ, Chiu C.

Nat Commun. 2015 Dec 21;6:10224. doi: 10.1038/ncomms10224. Erratum in: Nat Commun. 2016;7:11011.

20.

Differences in antigen-specific CD4+ responses to opportunistic infections in HIV infection.

Pollock KM, Montamat-Sicotte DJ, Cooke GS, Kapembwa MS, Kon OM, Grass L, Sampson RD, Taylor GP, Lalvani A.

Immun Inflamm Dis. 2015 Sep;3(3):141-53. doi: 10.1002/iid3.50. Epub 2015 Apr 29.

Supplemental Content

Loading ...
Support Center